NEW YORK (GenomeWeb) – Improving diagnosis for children with rare diseases is one of the major goals of the recently-founded Children's National Rare Disease Institute (CNRDI) in Washington, DC, and both the structured use of clinical information and targeted genomic testing will likely help with that.

The institute, which was announced last month, is part of Children's National Health System and evolved from its existing Division of Genetics and Metabolism. It plans to focus exclusively on advancing the care and treatment of children and adults with rare genetic diseases.